Profile of Eyelid Tumours: Histopathological Examination and Relative Frequency At A Tertiary Centre In North-West Rajasthan

Purpose:- To analyze the demography and relative frequency and to compare the clinical diagnosis with histopathological diagnosis of eyelid tumours at a tertiary care centre in North-West Rajasthan. Methods:- Retrospective data of patients with eyelid tumours from June 2012 to June 2014 and prospect...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahendra Kumar Jangir, Anju Kochar, Nabab Ali Khan, Meenu Jaju
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-04-01
Series:Delhi Journal of Ophthalmology
Subjects:
Online Access:https://journals.lww.com/10.7869/djo.305
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose:- To analyze the demography and relative frequency and to compare the clinical diagnosis with histopathological diagnosis of eyelid tumours at a tertiary care centre in North-West Rajasthan. Methods:- Retrospective data of patients with eyelid tumours from June 2012 to June 2014 and prospective data of patients from July 2014 to December 2016 were analyzed. Data were collected and stratified based on age, gender, type and subtype, location of tumour and histopathological diagnosis. Results:- A total of 125 patients were evaluated, of which, 54.4% (68) were male and 45.6% (57) were female. The mean age of the patients was 37.28+21.75 years. Out of the total cases, 108 (86.4%) cases were benign and 17 (13.60%) were malignant eyelid tumours. The most common benign tumour included epidermal cyst (21.3%), demoid cyst (13.89%), intradermal naevus (12.03%) and haemangioma (12.03%). The most frequent malignant tumours included sebaceous gland carcinoma (47%), basal cell carcinoma (29%) and squamous cell carcinoma (24%). Conclusion:- Epidermal cyst was the most common benign tumour followed by demoid cyst, intradermal naevus and haemangioma and sebaceous gland carcinoma was the most common malignant tumour, followed by basal and squamous cell carcinoma.
ISSN:0972-0200
2454-2784